It’s six months since the Zero Childhood Cancer personalised medicine national clinical trial began. We'd like to share some of our progress with you.
Ground-breaking virtual reality (VR) technology is allowing multiple scientists to see inside a human cell at the same time.
If doctors can reliably tell which children are most likely to get their leukaemia back, they can offer more intensive treatment options to prevent it.
This week our higher degree students presented their research at the 5th annual UNSW Paediatric Research Week.
Brain cancers are the leading disease-related cause of death in Australian children. In this article, first published in The Conversation, A/Prof David Ziegler explains what we can learn from improving childhood leukaemia survival.
WA children with the most aggressive cancers will benefit from an Australian-first personalised medicine clinical trial.
We presented exciting results from preclinical drug testing at a cancer conference this week in the US.
In a landmark moment for brain cancer research, the Australian Government has established a $100 million fund to search for cures and support clinical trials.
Two of our top researchers have been recognised for their outstanding contributions to science and innovation.
How we got to now in our understanding of MRP1, a protein that ejects chemotherapy drugs from tumour cells and stops them stopping cancer. We're exploring future drugs that target it.